JP2017535292A5 - - Google Patents

Download PDF

Info

Publication number
JP2017535292A5
JP2017535292A5 JP2017545528A JP2017545528A JP2017535292A5 JP 2017535292 A5 JP2017535292 A5 JP 2017535292A5 JP 2017545528 A JP2017545528 A JP 2017545528A JP 2017545528 A JP2017545528 A JP 2017545528A JP 2017535292 A5 JP2017535292 A5 JP 2017535292A5
Authority
JP
Japan
Prior art keywords
modified
cells
cell
tumor
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017545528A
Other languages
English (en)
Japanese (ja)
Other versions
JP7146397B2 (ja
JP2017535292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/061189 external-priority patent/WO2016081518A2/en
Publication of JP2017535292A publication Critical patent/JP2017535292A/ja
Publication of JP2017535292A5 publication Critical patent/JP2017535292A5/ja
Priority to JP2020214661A priority Critical patent/JP7317793B2/ja
Application granted granted Critical
Publication of JP7146397B2 publication Critical patent/JP7146397B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017545528A 2014-11-17 2015-11-17 改変γδT細胞 Active JP7146397B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020214661A JP7317793B2 (ja) 2014-11-17 2020-12-24 改変γδT細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462080500P 2014-11-17 2014-11-17
US62/080,500 2014-11-17
PCT/US2015/061189 WO2016081518A2 (en) 2014-11-17 2015-11-17 Engineered gamma delta t-cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020214661A Division JP7317793B2 (ja) 2014-11-17 2020-12-24 改変γδT細胞

Publications (3)

Publication Number Publication Date
JP2017535292A JP2017535292A (ja) 2017-11-30
JP2017535292A5 true JP2017535292A5 (enExample) 2019-01-10
JP7146397B2 JP7146397B2 (ja) 2022-10-04

Family

ID=56014675

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017545528A Active JP7146397B2 (ja) 2014-11-17 2015-11-17 改変γδT細胞
JP2020214661A Active JP7317793B2 (ja) 2014-11-17 2020-12-24 改変γδT細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020214661A Active JP7317793B2 (ja) 2014-11-17 2020-12-24 改変γδT細胞

Country Status (14)

Country Link
US (2) US11135245B2 (enExample)
EP (2) EP3220926B1 (enExample)
JP (2) JP7146397B2 (enExample)
KR (1) KR102660362B1 (enExample)
CN (2) CN117143814A (enExample)
AU (2) AU2015350103A1 (enExample)
CA (1) CA2966634C (enExample)
DK (1) DK3220926T3 (enExample)
ES (1) ES3023783T3 (enExample)
IL (2) IL297773B2 (enExample)
MX (1) MX2017006408A (enExample)
RU (1) RU2756247C2 (enExample)
WO (1) WO2016081518A2 (enExample)
ZA (1) ZA201703505B (enExample)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE030210T2 (en) 2004-11-24 2017-04-28 Hutchinson Fred Cancer Res Methods for using IL-21 to identify adoptive immunotherapy and tumor antigens
GB201506423D0 (en) 2015-04-15 2015-05-27 Tc Biopharm Ltd Gamma delta T cells and uses thereof
DK3220926T3 (da) 2014-11-17 2025-03-24 Adicet Therapeutics Inc Konstruerede gamma-delta-t-celler
AU2016212777B2 (en) 2015-01-27 2021-11-18 LAVA Therapeutics N.V. Single domain antibodies targeting CD1d
GB201507368D0 (en) 2015-04-30 2015-06-17 Ucl Business Plc Cell
PL3307875T3 (pl) * 2015-06-09 2022-08-01 Lymphact - Lymphocyte Activation Technologies, S.A. Sposoby wytwarzania limfocytów t tcr gamma delta+
ES2910709T3 (es) 2015-09-03 2022-05-13 Uab Res Found Células T modificadas genéticamente resistentes a fármacos y procedimientos de utilización de las mismas
CA3023993A1 (en) 2016-05-12 2017-11-16 Adicet Bio Inc. Methods for selective expansion of .gamma..delta. t-cell populations and compositions thereof
US10426796B2 (en) * 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US12350349B2 (en) 2016-08-03 2025-07-08 Washington University Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors
KR102032354B1 (ko) * 2016-11-11 2019-10-16 가톨릭대학교 산학협력단 신규한 배양보조세포 및 이를 이용한 감마 델타 t 세포의 증식 방법
CA3044593A1 (en) 2016-11-22 2018-05-31 TCR2 Therapeutics Inc. Compositions and methods for tcr reprogramming using fusion proteins
JP2020513754A (ja) * 2016-12-21 2020-05-21 ティーシーアール2 セラピューティクス インク. がん治療用に操作されたt細胞
CN110494558B (zh) * 2017-02-08 2023-07-07 新加坡科技研究局 Gamma delta t细胞和增强其杀肿瘤活性的方法
EP4417210A1 (en) 2017-03-15 2024-08-21 Orca Biosystems, Inc. Compositions and methods for hematopoietic stem cell transplants
GB201707048D0 (en) 2017-05-03 2017-06-14 King S College London Expansion of gamma delta cells, compositions, and methods of use thereof
US12384830B2 (en) * 2017-06-02 2025-08-12 Regents Of The University Of Minnesota Compositions and methods for improving immunotherapy
WO2018236986A1 (en) * 2017-06-20 2018-12-27 The Trustees Of Columbia University In The City Of New York Engineered t-cell receptors and methods of their use
IL299348B2 (en) 2017-06-28 2025-05-01 Regeneron Pharma Antigen-binding proteins against human papillomavirus and methods of using them
WO2019053272A1 (en) * 2017-09-15 2019-03-21 King's College London COMPOSITIONS AND METHODS FOR IMPROVING T GAMMA DELTA LYMPHOCYTES IN INTESTINE
TWI687227B (zh) * 2017-10-03 2020-03-11 生倍科技股份有限公司 用於t細胞免疫療法之組合及其用途
CN109777778B (zh) * 2017-11-14 2023-07-18 中国科学院广州生物医药与健康研究院 一种基因改造的γδT细胞
CA3082818A1 (en) 2017-11-15 2019-05-23 Adicet Bio Inc. Methods for selective expansion of .delta.3 .gamma..delta. t-cell populations and compositions thereof
DE102017127984B4 (de) 2017-11-27 2019-12-05 Immatics US, Inc. Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
CN108129566B (zh) * 2017-12-31 2021-05-11 中国科学院武汉病毒研究所 靶向间皮素的c-型单域抗体及其制备方法与应用
US12215154B2 (en) 2018-01-19 2025-02-04 The Trustees Of The University Of Pennsylvania Compositions and methods for targeting γδ T cells with chimeric antigen receptors
WO2019178463A1 (en) * 2018-03-16 2019-09-19 H. Lee Moffitt Cancer Center And Research Institute Inc. Chimeric antigen receptors with mutated cd28 phosphorylation sites
GB201804701D0 (en) 2018-03-23 2018-05-09 Gammadelta Therapeutics Ltd Lymphocytes expressing heterologous targeting constructs
US20210230637A1 (en) * 2018-05-08 2021-07-29 Osaka University Method for producing homozygous cells
CN110577932A (zh) * 2018-06-07 2019-12-17 亘喜生物科技(上海)有限公司 一种脐带血来源的嵌合抗原受体t细胞
US20210277148A1 (en) * 2018-07-18 2021-09-09 Amgen Inc. Chimeric receptors to steap1 and methods of use thereof
CN118459590A (zh) * 2018-08-01 2024-08-09 感应检查疗法公司 抗btn3a抗体及其在治疗癌症或感染性病症中的用途
CN108949685B (zh) * 2018-08-02 2022-03-29 吉林大学第一医院 一种体外诱导扩增高杀伤活性γδT细胞的方法
WO2020033464A1 (en) 2018-08-07 2020-02-13 H. Lee Moffitt Cancer Center And Research Institute Inc. Car t-cells for the treatment of bone metastatic cancer
US20210177903A1 (en) * 2018-08-07 2021-06-17 H. Lee Moffitt Cancer Center And Research Institute, Inc. Car t-cells for the treatment of bone metastatic cancer
CN112105724A (zh) * 2018-08-09 2020-12-18 深圳华大生命科学研究院 无内源hla基因背景的抗原递呈细胞系的构建方法、抗原递呈细胞系及其用途
US20210301260A1 (en) * 2018-08-10 2021-09-30 Kyoto University Method for producing cd3-positive cell
CN110423757B (zh) * 2018-08-11 2021-03-30 广东天科雅生物医药科技有限公司 一种工程化核酸、t细胞及其应用和产生方法
CN109161533B (zh) * 2018-08-28 2020-07-24 深圳市菲鹏生物制药股份有限公司 无血清培养组合物及其应用
WO2020060406A1 (en) 2018-09-19 2020-03-26 Lava Therapeutics B.V. Novel bispecific antibodies for use in the treatment of hematological malignancies
BR112021006254A2 (pt) 2018-10-01 2021-07-27 Adicet Bio, Inc. composições e métodos relativos a células t¿d engenheiradas e não engenheiradas para tratamento de tumores sólidos
JP7687952B2 (ja) * 2018-10-01 2025-06-03 アディセット セラピューティクス, インク. 血液腫瘍を治療するための遺伝子操作しているγδ-T細胞及び遺伝子操作していないγδ-T細胞に関する組成物及び方法
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
EP3870602A1 (en) 2018-10-23 2021-09-01 Regeneron Pharmaceuticals, Inc. Ny-eso-1 t cell receptors and methods of use thereof
GB201818243D0 (en) 2018-11-08 2018-12-26 Gammadelta Therapeutics Ltd Methods for isolating and expanding cells
AU2019394877A1 (en) 2018-12-03 2021-06-17 Adicet Therapeutics, Inc. Methods for selective in vivo expansion of gamma delta T-cell populations and compositions thereof
CN111544585B (zh) * 2019-02-11 2024-12-27 北京卡替医疗技术有限公司 一种可助推免疫细胞在体内扩增的佐剂
WO2020166729A1 (ja) * 2019-02-14 2020-08-20 学校法人獨協学園獨協医科大学 T細胞ワクチン
EP3927735A4 (en) * 2019-02-18 2023-09-06 Memorial Sloan Kettering Cancer Center COMBINATIONS OF MULTIPLE CHIMERIC ANTIGEN RECEPTORS FOR IMMUNOTHERAPY
US20220143086A1 (en) * 2019-02-24 2022-05-12 Gamida Cell Ltd. Method of homing and retention of gammadelta t cells, optionally with natural killer cells, for generating cell compositions for use in therapy
US20220143087A1 (en) * 2019-03-08 2022-05-12 Klinikum Der Universitat Munchen Ccr8 expressing lymphocytes for targeted tumor therapy
CN109758590B (zh) * 2019-03-28 2022-02-11 广东工业大学 一种用于筛选人前列腺癌肿瘤抗原表位肽的方法
KR20220030208A (ko) * 2019-03-30 2022-03-10 바이오엔테크 유에스 인크. T 세포 조성물의 제조를 위한 조성물 및 방법, 및 그의 용도
WO2020214957A1 (en) 2019-04-19 2020-10-22 Tcrcure Biopharma Corp. Anti-pd-1 antibodies and uses thereof
US12479890B2 (en) 2019-04-26 2025-11-25 The University Of North Carolina At Chapel Hill Chimeric antigen receptor constructs and their use in CAR-T cells
JP7686571B2 (ja) * 2019-05-08 2025-06-02 ヤンセン バイオテツク,インコーポレーテツド T細胞媒介性免疫を調節するための材料及び方法
AU2020314956A1 (en) * 2019-07-17 2022-03-03 Case Western Reserve University Long lived T cells for treating HIV infection
WO2021016652A1 (en) * 2019-07-29 2021-02-04 The University Of Melbourne METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS
EP4013504A1 (en) * 2019-08-16 2022-06-22 GammaDelta Therapeutics Limited Novel anti-tcr delta variable 1 antibodies
CN114555785B (zh) * 2019-10-17 2024-12-06 香港大学 制备v-t细胞衍生的外泌体以治疗epstein-barr病毒相关癌症的方法
KR20220116154A (ko) 2019-10-31 2022-08-22 모르포시스 아게 항-cd19 항체 및 감마 델타 t-세포를 포함하는 항-종양 병용 요법
CN115397976A (zh) * 2019-12-03 2022-11-25 阿迪塞特生物股份有限公司 用多价药剂及其组合物扩增γδT细胞群的方法
EP4093753A1 (en) 2020-01-24 2022-11-30 Regeneron Pharmaceuticals, Inc. Preferentially expressed antigen in melanoma (prame) t cell receptors and methods of use thereof
PH12022552290A1 (en) * 2020-03-03 2023-12-18 Janssen Biotech Inc ?d T CELLS AND USES THEREOF
US12365871B2 (en) 2020-04-28 2025-07-22 Lyell Immunopharma, Inc. Methods for culturing cells
CN115996733A (zh) * 2020-06-22 2023-04-21 南京传奇生物科技有限公司 用于免疫疗法的基因工程化γδT细胞
CN116323667A (zh) 2020-07-08 2023-06-23 拉法医疗股份有限公司 结合PSMA和γ-δT细胞受体的抗体
CN116333999A (zh) * 2020-07-14 2023-06-27 广州泛恩生物科技有限公司 基于cxcl13阳性t细胞的用于杀伤肿瘤的tcr-t细胞及其制备方法和应用
EP4288074A4 (en) * 2021-02-08 2025-04-30 The Regents of University of California Regulation of butvrophilin subfamily 3 member a1 (btn3a1, cd277)
GB202105113D0 (en) * 2021-04-09 2021-05-26 Gammadelta Therapeutics Ltd Novel method
WO2023069322A1 (en) * 2021-10-20 2023-04-27 University Of Pittsburgh – Of The Commonwealth System Of Higher Education Methods and materials for expanding tumor infiltrating gamma-delta t cells
WO2023092119A2 (en) 2021-11-22 2023-05-25 Ludwig Institute For Cancer Research Ltd Methods for predicting responsiveness to a cancer therapy
CA3240081A1 (en) * 2021-12-05 2023-06-08 Blake AFTAB Treatment of b cell malignancies
KR20230105166A (ko) 2022-01-03 2023-07-11 주식회사 이뮤노맥스 감마-델타 t 세포의 증식 배양 방법
CN114149978B (zh) * 2022-02-09 2022-04-26 深圳博雅感知药业有限公司 制备car-t细胞的方法
MX2024010047A (es) 2022-02-16 2024-08-26 Priothera Sas Metodos de tratamiento con celulas car en combinacion con moduladores del receptor s1p.
GB202204926D0 (en) 2022-04-04 2022-05-18 Gammadelta Therapeutics Ltd Method for expanding gammadelta T cells
WO2023242434A1 (en) * 2022-06-17 2023-12-21 Gadeta B.V. Modified immune cells
CN115624618A (zh) * 2022-09-16 2023-01-20 深圳善乐生物科技有限公司 一种HPV多肽抗原负载γδT细胞在HPV阳性宫颈癌免疫治疗中的应用
WO2024097642A1 (en) 2022-10-31 2024-05-10 Regeneron Pharmaceuticals, Inc. Methods of treating cancer with a combination of adoptive cell therapy and a targeted immunocytokine
CN120882754A (zh) 2023-04-07 2025-10-31 瑞泽恩制药公司 用淋巴毒素β受体激动剂治疗癌症的方法
WO2024243511A1 (en) 2023-05-25 2024-11-28 Regeneron Pharmaceuticals, Inc. T cell receptors that bind presented hpv16-, mart1-, cmv-, ebv-, or influenza- peptides
US12221483B1 (en) * 2024-01-30 2025-02-11 China Medical University Hospital Fusion protein and nucleic acid encoding sequence thereof, and uses of the same
WO2025165915A1 (en) * 2024-01-31 2025-08-07 Adicet Therapeutics, Inc. Compositions and methods for enhancing engineered t cell therapies
WO2025229538A1 (en) * 2024-05-01 2025-11-06 Janssen Biotech, Inc. Materials, methods, and systems for cellular expansion of gamma delta t-cells

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260223A (en) 1986-07-03 1993-11-09 President & Fellows Of Harvard College Methods for detection of human gamma, γ T cell receptor
US5185250A (en) 1986-07-03 1993-02-09 T Cell Sciences, Inc. Human γ, δT cell antigen receptor polypeptides and nucleic acids
JPH07505773A (ja) 1992-04-03 1995-06-29 ヤング アレキサンダー ティー 標的化されたウイルスベクターを用いた遺伝子治療
CA2110946A1 (en) 1992-12-09 1994-06-10 Elazar Rabbani Induction of immunocompatibility by nucleic acid
WO2000078348A1 (en) 1999-06-17 2000-12-28 University Of Vermont And State Agricultural College Autologous adoptive immunotherapy with primed antigen-specific t cells or b cells
AU7729000A (en) 1999-09-30 2001-04-30 National Jewish Medical And Research Center Modulation of gammadelta t cells to regulate airway hyperresponsiveness
US6737398B1 (en) 1999-09-30 2004-05-18 National Jewish Medical And Research Center Modulation of γδ T cells to regulate airway hyperresponsiveness
JP4968498B2 (ja) 2002-01-23 2012-07-04 ユニバーシティ オブ ユタ リサーチ ファウンデーション ジンクフィンガーヌクレアーゼを用いる、標的化された染色体変異誘発
CN1306027C (zh) * 2002-12-12 2007-03-21 中国医学科学院基础医学研究所 一种体外扩增γδT淋巴细胞的方法
WO2004092741A2 (en) 2003-04-14 2004-10-28 Montana State University Mapping discontinuous antibody or aptamer epitopes for protein structure determination and other applications
US7985739B2 (en) 2003-06-04 2011-07-26 The Board Of Trustees Of The Leland Stanford Junior University Enhanced sleeping beauty transposon system and methods for using the same
AU2005250499B2 (en) * 2004-06-03 2011-12-08 Novimmune S.A. Anti-CD3 antibodies and methods of use thereof
US7340913B2 (en) 2004-08-05 2008-03-11 Manitowoc Foodservice Companies, Inc. Ice machine and ice-making assembly including a water distributor
US20080026986A1 (en) 2006-06-05 2008-01-31 Rong-Fu Wang Reversal of the suppressive function of specific t cells via toll-like receptor 8 signaling
LT3339445T (lt) * 2006-09-08 2020-10-26 Abbvie Bahamas Ltd. Baltymai, suryšantys interleukiną 13
WO2010027797A1 (en) 2008-08-26 2010-03-11 Macrogenics Inc. T-cell receptor antibodies and methods of use thereof
EA031322B1 (ru) 2010-01-22 2018-12-28 Дау Агросайенсиз Ллс Клетка или клеточная линия для экспрессии экзогенных нуклеотидных последовательностей и применение клетки или клеточной линии
EP2596011B1 (en) * 2010-07-21 2018-10-03 Sangamo Therapeutics, Inc. Methods and compositions for modification of a hla locus
EP2694553B1 (en) 2011-04-01 2017-10-11 Memorial Sloan-Kettering Cancer Center T cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2
WO2012156958A2 (en) 2011-05-19 2012-11-22 Instituto De Medicina Molecular Cell line of lymphocytes comprising gamma-delta t cells, composition and production method thereof
WO2013074916A1 (en) * 2011-11-18 2013-05-23 Board Of Regents, The University Of Texas System Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
CN103987405B (zh) 2011-11-28 2017-03-29 默克专利股份公司 抗pd‑l1抗体及其用途
CN103130894B (zh) * 2011-11-30 2017-04-12 中国医学科学院基础医学研究所 抗人γδTCR单克隆抗体的重组单链抗体G5‑4ScFv及其编码基因与应用
EP2684600A1 (en) 2012-07-10 2014-01-15 Laboratoires Meiners Sarl Core-shell capsules and methods for encapsulation of reactive ingredients by diffusional exchange through spherical capsule membranes
WO2014072446A1 (en) 2012-11-08 2014-05-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for inducing il-2-free proliferation of gamma delta t cells
CN102994448A (zh) 2012-12-13 2013-03-27 上海柯莱逊生物技术有限公司 一种体外扩增γδT细胞的方法
ES2750550T3 (es) 2013-03-01 2020-03-26 Univ Minnesota Corrección de gen a base de TALEN
WO2015061694A2 (en) 2013-10-25 2015-04-30 Board Of Regents, The University Of Texas System Polyclonal gamma delta t cells for immunotherapy
EA039086B1 (ru) * 2014-04-10 2021-12-01 Лава Терапьютикс Н.В. Иммуноглобулины, связывающие человеческие v9v2 т-клеточные рецепторы
DK3220926T3 (da) 2014-11-17 2025-03-24 Adicet Therapeutics Inc Konstruerede gamma-delta-t-celler
CN114958738A (zh) 2015-06-09 2022-08-30 淋巴-淋巴细胞活化技术公司 用于生产TCRγδ+T细胞的方法
MA42895A (fr) 2015-07-15 2018-05-23 Juno Therapeutics Inc Cellules modifiées pour thérapie cellulaire adoptive
US10519236B2 (en) 2018-01-23 2019-12-31 New York University Antibodies specific to delta 1 chain of T cell receptor

Similar Documents

Publication Publication Date Title
JP2017535292A5 (enExample)
US12371663B2 (en) Engineered γδ T-cells
TWI828625B (zh) 引導及導航控制蛋白質以及彼之製造及使用方法
JP6640726B2 (ja) キメラ抗原受容体及びその製造方法
JP2016520074A5 (enExample)
CN117285641A (zh) 制导和导航控制蛋白及其制备和使用方法
JP2017533706A5 (enExample)
CN115003698A (zh) 抗tcr抗体分子及其用途
CN107206025A (zh) 用于过继细胞治疗的方法和组合物
US20250002855A1 (en) Methods for expanding t cells for the treatment of cancer and related malignancies
WO2013175237A1 (en) Composition comprising a cd2 ligation agent and a nkg2d ligation agent
JP2021502816A5 (enExample)
Garber et al. Adoptive T-cell therapy for Leukemia
US20220280564A1 (en) Methods for expanding t cells for the treatment of cancer and related malignancies
CN118891290A (zh) 细胞免疫疗法的组合物和方法
WO2024193714A1 (zh) 细胞免疫疗法的组合物和方法
WO2025213573A1 (zh) 细胞免疫疗法的组合物和方法
WO2024240112A1 (zh) 免疫效应细胞及其应用
CN121152813A (zh) 细胞免疫疗法的组合物和方法
RU2021108422A (ru) Способы получения клеток, экспрессирующих химерный антигенный рецептор
HK1242585B (en) Engineered gamma delta t-cells
HK1242585A1 (en) Engineered gamma delta t-cells
NZ742136A (en) Improved methods for manufacturing adoptive cell therapies